Literature DB >> 18337755

Hypertension, concurrent cardiovascular risk factors and mortality: the Singapore Cardiovascular Cohort Study.

J Lee1, S Ma, D Heng, Sk Chew, K Hughes, Es Tai.   

Abstract

The current hypertension (HTN) guidelines recommend the assessment of other cardiovascular disease (CVD) risk factors in individuals with HTN for further management. Few studies in Asian populations have been published to identify the outcome of individuals with HTN and other CVD risk factors. This study aims to assess the effect of HTN alone, and in combination with other CVD risk factors on all-cause and CVD mortality. Three cross-sectional studies carried out in Singapore (baseline 1982--1995) consisting of 5830 persons were grouped by the absence or presence of HTN and CVD risk factors. They were followed-up (mean 14.1 years) by linkage with the National Death Register. Cox's proportional hazards model was used to obtain adjusted hazard ratios (HRs) for risk of mortality. HTN individuals with either <2 CVD risk factors (adjusted HR 1.4; 95% confidence interval (CI) 1.0-1.8) or > or =2 CVD risk factors (adjusted HR 2.3; 95% CI 1.9-3.0) were at increased risk of all-cause mortality compared to normotensive individuals. The findings were similar for CVD mortality. HTN individuals who also smoked or had diabetes were at highest risk of all-cause mortality, whereas those with elevated total cholesterol/high-density lipoprotein cholesterol, smoked or diabetes had the highest risk for CVD mortality. These findings show that in HTN individuals it is important to assess the presence of other CVD risk factors and manage accordingly.

Entities:  

Mesh:

Year:  2008        PMID: 18337755     DOI: 10.1038/jhh.2008.16

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  4 in total

1.  Ideal cardiovascular health status and its association with socioeconomic factors in Chinese adults in Shandong, China.

Authors:  J Ren; X L Guo; Z L Lu; J Y Zhang; J L Tang; X Chen; C C Gao; C X Xu; A Q Xu
Journal:  BMC Public Health       Date:  2016-09-07       Impact factor: 3.295

2.  Cost-Effectiveness of Dapagliflozin versus Acarbose as a Monotherapy in Type 2 Diabetes in China.

Authors:  Shuyan Gu; Yiming Mu; Suodi Zhai; Yuhang Zeng; Xuemei Zhen; Hengjin Dong
Journal:  PLoS One       Date:  2016-11-02       Impact factor: 3.240

3.  Assessment of Cardiovascular Risk Factors and Their Interactions in the Risk of Coronary Heart Disease in Patients with Type 2 Diabetes with Different Weight Levels, 2013-2018.

Authors:  Chenchen Wang; Demei Ye; Zuoling Xie; Xi Huang; Zheng Wang; Haiyan Shangguan; Wenwen Zhu; Shaohua Wang
Journal:  Diabetes Metab Syndr Obes       Date:  2021-10-14       Impact factor: 3.168

4.  Rate and Risk of All Cause Mortality among People with Known Hypertension in a Rural Community of Southern Kerala, India: The Results from the Prolife Cohort.

Authors:  Anu Kuriakose; Thekkumkara Surendran Nair Anish; Biju Soman; Ron Thomas Varghese; Thekkumkara Prabhakaran Sreelal; Alice Matilda Mendez; Anitha Abraham
Journal:  Int J Prev Med       Date:  2014-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.